Publications by authors named "Bruno Garibaldi"

Claim this Profile
C
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Calogero Vetro, Bruno Garibaldi, Francesco Grimaldi, Patrizia Chiusolo, Carla Filì

Blood Cancer J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology.
Concetta Conticello, Vittorio Del Fabro, Alessandra Romano, Anna Mele, Roberto Mina, Bruno Garibaldi

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy.
Concetta Conticello, Vittorio Del Fabro, Alessandra Romano, Anna Mele, Roberto Mina, Bruno Garibaldi

Ann Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Calogero Vetro, Bruno Garibaldi, Francesco Grimaldi, Patrizia Chiusolo, Carla Filì

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.
Andrea Duminuco, Patrick Harrington, Vittorio Del Fabro, Elvira Scalisi, Gabriella Santuccio, Bruno Garibaldi

Pharmaceuticals (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor.
Giuseppe Bertuglia, Bruno Garibaldi, Andrea Casson, Barbara Sarina, Francesca Gay

Bone Marrow Transplant· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Salvatore Leotta, Uros Markovic, Andrea Duminuco, Antonino Mulè, Ferdinando Porretto, Bruno Garibaldi

Ann Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over.
Annalisa Condorelli, Bruno Garibaldi, Caterina Gagliano, Alessandra Romano, Vittorio Del Fabro

Acta Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Manlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, Alessandro Allegra, Uroš Markovic, Bruno Garibaldi

Curr Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
Francesca Palandri, Elena Rossi, Giuseppe Auteri, Massimo Breccia, Simona Paglia, Bruno Garibaldi

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the Gene: Two Case Reports.
Maria Stella Pennisi, Sandra Di Gregorio, Elena Tirrò, Chiara Romano, Andrea Duminuco, Bruno Garibaldi

Hematol Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, Francesco Mannelli, Valerio De Stefano, Bruno Garibaldi

Cancer Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Handheld Ultrasound or Conventional Ultrasound Devices in Patients Undergoing HCT: A Validation Study.
Andrea Duminuco, Alessandra Cupri, Rosario Massimino, Salvatore Leotta, Giulio Antonio Milone, Bruno Garibaldi

J Clin Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
Enrica Antonia Martino, Concetta Conticello, Elena Zamagni, Vincenzo Pavone, Salvatore Palmieri, Bruno Garibaldi

Hematol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Previous therapy with immune checkpoint inhibitor as a cause of hypothyroidism, myositis, and renal insufficiency in a candidate for allogeneic hematopoietic transplantation.
Andrea Duminuco, Alessandra Cupri, Giulio A Milone, Carmelita Marcantoni, Salvatore Leotta, Bruno Garibaldi

Transpl Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting.
Andrea Duminuco, Antonella Nardo, Bruno Garibaldi, Calogero Vetro, Anna Longo

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.
Fortunato Morabito, Elena Zamagni, Concetta Conticello, Vincenzo Pavone, Salvatore Palmieri, Bruno Garibaldi

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
Fortunato Morabito, Elena Zamagni, Concetta Conticello, Vincenzo Pavone, Salvatore Palmieri, Bruno Garibaldi

Eur J Haematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes.
Calogero Vetro, Valeria Di Giacomo, Donato Mannina, Silvana Magrin, Antonio Mulè, Bruno Garibaldi

J Clin Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives.
Salvatore Leotta, Annalisa Condorelli, Roberta Sciortino, Giulio Antonio Milone, Claudia Bellofiore, Bruno Garibaldi

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology.
Giuseppe Milone, Claudia Bellofiore, Salvatore Leotta, Giulio Antonio Milone, Alessandra Cupri, Bruno Garibaldi

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study.
Uros Markovic, Alessandra Romano, Claudia Bellofiore, Annalisa Condorelli, Bruno Garibaldi

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database.
Lucia Gozzo, Calogero Vetro, Serena Brancati, Laura Longo, Daniela Cristina Vitale, Bruno Garibaldi

Front Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic innovation for multi-resistant candidemics: Synergy of isavuconazole and caspofungin association.
Andrea Duminuco, Elisa Mauro, Giuseppe A M Palumbo, Bruno Garibaldi, Marina Parisi

Hematol Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.
Concetta Conticello, Alessandra Romano, Vittorio Del Fabro, Enrica Antonia Martino, Valeria Calafiore, Bruno Garibaldi

J Clin Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis